Cardiac Computarized Tomography in Infective Endocarditis (cardiac CT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00550823
First received: October 27, 2007
Last updated: October 29, 2007
Last verified: October 2007
  Purpose

The diagnosis of infective endocarditis is based on the results of blood culture and findings on transeosophageal echocardiography. Cardiac computarized tomography is a new modality, mainly used for the imaging of coronary arteries. Its use in the diagnosis of infective endocarditis is not well known.The purpose of this study is to establish the use of cardiac CT in infective endocarditis.


Condition Intervention
Infective Endocarditis
Device: Cardiac CT 0BRILLIANT 64

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: The Use of Cardiac Computarized Tomography in Infective Endocarditis

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • The diagnostic capacity of cardiac CT in comparison with TEE in the diagnosis of infective endocarditis [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • Assessment of cardiac function in patients with infective endocarditis [ Time Frame: 1 year ]

Estimated Enrollment: 20
Study Start Date: November 2007
Estimated Study Completion Date: November 2008
Arms Assigned Interventions
Experimental: A,1 Device: Cardiac CT 0BRILLIANT 64
Cardiac CT

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with infective endocarditis

Exclusion Criteria:

  • Allergy to contrast agent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00550823

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Ori Elkayam, M.D Tel Aviv Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00550823     History of Changes
Other Study ID Numbers: 362-07
Study First Received: October 27, 2007
Last Updated: October 29, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Endocarditis
Endocarditis, Bacterial
Bacterial Infections
Cardiovascular Diseases
Cardiovascular Infections
Heart Diseases
Infection

ClinicalTrials.gov processed this record on October 29, 2014